More Magnesium Won’t Help You Sleep

your diet, supplementation may have been addressing an underlying deficiency — and continuing it may make sense while also examining other causes.

Several factors deplete magnesium independent of dietary intake: high alcohol consumption, prolonged psychological stress, high-volume exercise without dietary compensation, proton pump inhibitor use (which reduces magnesium absorption in the gut), and type 2 diabetes. If any apply, your requirement may be higher than standard dietary estimates suggest.

Stress depletes magnesium through elevated cortisol, which increases urinary magnesium excretion. High-volume training depletes it through sweat losses that dietary intake rarely compensates for. Alcohol interferes with renal reabsorption, meaning the gut may be absorbing adequate amounts while the kidneys are excreting them at an elevated rate. If two or more of these factors apply simultaneously, the cumulative depletion can exceed what dietary adjustments alone will reverse.

One complication with assessment: serum magnesium reflects roughly 1% of total body magnesium. The other 99% is intracellular. Serum levels can read within range while intracellular stores are low. RBC (red blood cell) magnesium testing provides a closer picture of tissue-level status, though it is not standard in routine panels. If you have been supplementing for several months without appreciable improvement and dietary intake appears adequate, RBC magnesium testing is one avenue to pursue before concluding that magnesium is irrelevant to your pattern.

If dietary intake is already adequate and magnesium has only partially helped, the remaining disruption is likely driven by factors other than magnesium status. At that point, form and dose are no longer the productive question.

2. Separate what magnesium addressed from what it didn’t.

Write down what has and hasn’t changed. Are you still waking between 2am and 4am? Is it difficult to return to sleep once awake? Do you feel alert at 3am in a way that is disproportionate to circumstances — nothing particular to worry about, just wide awake?

The character of that alertness matters as much as the timing. Is it a particular thought pattern, or general arousal with no content? Is there physical restlessness, or a heart rate that feels elevated? These details help distinguish cortisol-driven arousal from autonomic overactivation from circadian advance. Tracking the pattern over five to seven nights gives more usable information than a single night’s recollection. The time of waking, the type of alertness, and the ease of returning to sleep carry more information than the total number of awakenings. A log with those three variables, kept across seven to ten nights, gives you a working pattern rather than a single data point.

The timing of waking carries information. Waking at 2am with high alertness has different implications than waking at 4am with low-grade wakefulness. High alertness at 2–3am points toward cortisol and HPA (hypothalamic-pituitary-adrenal axis) patterning — the axis that regulates cortisol release. Calm but early waking without the ability to return to sleep points more toward circadian advance, a progressive movement of the sleep-wake cycle toward earlier timing that becomes more common past midlife. Whether you feel physiologically activated or awake without arousal narrows the likely cause.

3. Match the remaining disruption to the physiology driving it.

If your sleep changed around perimenopause or midlife without a lifestyle change you can point to, hormonal evaluation is the next variable to assess. In perimenopause, declining estrogen and progesterone affect sleep architecture through several mechanisms. Progesterone has direct sleep-promoting effects via GABA-A receptor activity — as levels drop, this effect diminishes. Estrogen regulates thermoregulation; as levels fluctuate, vasomotor events (hot flashes and night sweats) fragment sleep, often without the person identifying the trigger. In andropause, declining testosterone is associated with reduced slow-wave sleep, increased fragmentation, and higher rates of sleep-disordered breathing. Perimenopause and andropause sleep disruption does not respond to neural downregulation strategies — both require evaluating the hormonal variable directly.

If you have elevated inflammatory markers, chronic gut disruption, or signs of metabolic dysregulation — insulin resistance, elevated fasting glucose, increased visceral adiposity — sleep disruption driven by cytokine activity is a plausible contributor. Pro-inflammatory cytokines, including IL-6 and TNF-alpha, affect sleep architecture by disrupting slow-wave sleep and altering hypothalamic regulation of sleep-wake cycles. Gut dysbiosis can elevate circulating inflammatory markers through increased intestinal permeability, a state in which microbial products enter circulation and drive an immune response. Visceral adipose tissue is an independent source of inflammatory cytokines. In each case, the connection to sleep runs through cytokine-mediated changes in hypothalamic regulation that alter the sleep-wake cycle and reduce slow-wave depth.

If you wake consistently in the 1am–3am window without reflux awareness, nocturnal reflux merits evaluation, particularly past age 45. Many people with nocturnal reflux don’t experience heartburn while lying down. They may instead wake with a vague discomfort, a dry cough, or arouse from sleep without apparent cause. Lower esophageal sphincter tone tends to decrease with age, and the horizontal position removes gravity as a barrier to reflux. The microarousals this triggers can fragment sleep architecture — and register as unexplained middle-of-the-night waking — without a subjective burning sensation.

If waking looks like autonomic overactivation — high alertness, inability to return to sleep despite physical fatigue — stress load, exercise capacity, and HPA recovery are the relevant variables. Sympathetic nervous activity drives arousal: it raises heart rate, sharpens alertness, and mobilizes energy. During sleep, parasympathetic activation should dominate. When stress load is chronically elevated or recovery is inadequate, sympathetic activity remains elevated during periods it should not. This is measurable: HRV (heart rate variability) reflects the balance between sympathetic and parasympathetic activity. Low overnight HRV — particularly in the high-frequency band, which reflects parasympathetic tone — is associated with elevated arousal and disrupted sleep consolidation. If your overnight HRV has been trending low across several nights, autonomic overactivation is a more plausible explanation for your waking pattern than magnesium deficiency.

When the Bedtime Stack Is Reasonable but Incomplete

Some of you have moved well past magnesium. You’ve assembled a broader stack: glycine (which lowers core body temperature through peripheral vasodilation and is associated with slow-wave sleep improvement in small trials), L-threonate (a form of magnesium that crosses the blood-brain barrier and may support GABA-A receptor activity in hippocampal and cortical neurons), tart cherry extract (a natural source of melatonin and its precursors, with meta-analysis data showing reductions in sleep onset time and increases in total sleep time of roughly 20–40 minutes in healthy adults), ashwagandha — Withania somnifera — which has evidence from randomized trials for cortisol reductions of 14–28% over 8–12 weeks in adults under psychological stress. And sleep still isn’t where you want it.

Glycine’s human trial data is limited — a handful of small studies showing improved subjective sleep quality and reduced next-day fatigue, with some EEG-measured changes in sleep architecture. The mechanism is plausible: glycine-receptor-mediated peripheral vasodilation facilitates the core body temperature drop associated with sleep onset. L-threonate’s sleep-specific evidence in humans is thin; much of the supporting data comes from animal models. The sleep effects are mechanistically reasonable but not established in replicated human trials. Ashwagandha’s cortisol data is more consistent, though sleep-specific effects on objective measures vary across trials.

None of these compounds address circadian timing advance. None address hormonal changes in perimenopause or andropause. None address nocturnal reflux. None address the cytokine-mediated sleep disruption associated with gut dysbiosis or metabolic dysregulation.

A supplement stack built around neural downregulation and cortisol modulation is incomplete for disruption that is circadian, hormonal, inflammatory, or reflux-driven. The stack may be a reasonable component of your approach — it does not address the pattern that remains.

Wake-up timing, the character of alertness at waking, and what you feel when you can’t return to sleep are identifiable. Tracking these for one to two weeks — the time of waking, heart rate estimate, presence of content-laden thoughts versus undifferentiated arousal, ease or difficulty returning to sleep — usually reveals a consistent pattern. Once the pattern is visible, the contributing causes narrow. And once the causes narrow, the approach follows from the pattern.

What comes through consistently in the research and in my work with adults past 40: if magnesium helped partially, it identified deficiency as one contributing factor. The causes that remain after basic supplementation tend to be circadian, hormonal, inflammatory, or metabolic. Each is addressable. Each requires a different approach than the one you’ve already taken.

Circadian disruption responds to timing-based variables: light exposure timing, meal timing, temperature, and movement. Hormonal disruption requires evaluating the hormonal variable directly. Inflammatory disruption requires identifying the upstream driver — gut composition, metabolic status, or total inflammatory burden. Metabolic disruption responds to changes in insulin sensitivity, visceral fat, and glucose regulation. None of these are addressed by compounds built for neural downregulation.

The Circadian Mastery Protocol covers the timing inputs that set the conditions for deep, consolidated sleep past 40 — light exposure, meal timing, temperature anchoring, and movement timing. These are the variables that supplement stacks don’t reach, and that circadian-driven sleep disruption responds to directly. If your remaining disruption is pattern-based and persists despite supplementation, this is where I’d point you.

Get the Circadian Mastery Protocol →

References

• He C, Wang B, Chen X, Xu J, Yang Y, Yuan M. The Mechanisms of Magnesium in Sleep Disorders. Nat Sci Sleep. 2025 Oct 15;17:2639-2656. doi: 10.2147/NSS.S552646. PMID: 41116797; PMCID: PMC12535714.
• Arab A, Rafie N, Amani R, Shirani F. The Role of Magnesium in Sleep Health: a Systematic Review of Available Literature. Biol Trace Elem Res. 2023 Jan;201(1):121-128. doi: 10.1007/s12011-022-03162-1. Epub 2022 Feb 19. PMID: 35184264.
• Schuster J, Cycelskij I, Lopresti A, Hahn A. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nat Sci Sleep. 2025 Aug 30;17:2027-2040. doi: 10.2147/NSS.S524348. PMID: 40918053; PMCID: PMC12412596.
• Tunc M, Soysal P, Pasin O, Smith L, Rahmati M, Yigitalp V, Sahin S, Dramé M. Hypomagnesemia Is Associated with Excessive Daytime Sleepiness, but Not Insomnia, in Older Adults. Nutrients. 2023 May 25;15(11):2467. doi: 10.3390/nu15112467. PMID: 37299428; PMCID: PMC10255271.
• Mah, J., & Pitre, T. (2021). Oral magnesium supplementation for insomnia in older adults: A systematic review & meta-analysis. BMC Complementary Medicine and Therapies, 21(1), 125. https://pmc.ncbi.nlm.nih.gov/articles/PMC8053283/
• Schuster J, Cycelskij I, Lopresti A, Hahn A. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nat Sci Sleep. 2025 Aug 30;17:2027-2040. doi: 10.2147/NSS.S524348. PMID: 40918053; PMCID: PMC12412596.
• Möykkynen T, Uusi-Oukari M, Heikkilä J, Lovinger DM, Lüddens H, Korpi ER. Magnesium potentiation of the function of native and recombinant GABA(A) receptors. Neuroreport. 2001 Jul 20;12(10):2175-9. doi: 10.1097/00001756-200107200-00026. PMID: 11447329.
• Yijia Zhang, Cheng Chen, Liping Lu, Kristen L Knutson, Mercedes R Carnethon, Alyce D Fly, Juhua Luo, David M Haas, James M Shikany, Ka Kahe, Association of magnesium intake with sleep duration and sleep quality: findings from the CARDIA study, Sleep, Volume 45, Issue 4, April 2022, zsab276, https://doi.org/10.1093/sleep/zsab276
• Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013 May 17;8(5):e63773. doi: 10.1371/journal.pone.0063773. PMID: 23691095; PMCID: PMC3656905.
• Baskett JJ, Broad JB, Wood PC, Duncan JR, Pledger MJ, English J, Arendt J. Does melatonin improve sleep in older people? A randomised crossover trial. Age Ageing. 2003 Mar;32(2):164-70. doi: 10.1093/ageing/32.2.164. PMID: 12615559.